Gilenya Clinical Trials Gilenya RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Impact of Fingolimod Adherence on Outcomes
Condition:   Multiple Sclerosis Intervention:   Drug: Fingolimod Sponsor:   Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2021 Category: Research Source Type: clinical trials